More Healthcare Coverage

  • January 23, 2024

    UPenn's Retrial Bid Is Denied In $183M Birth Injury Case

    A Philadelphia judge said Tuesday that she won't grant a new trial to the Hospital of the University of Pennsylvania after it was hit with a $183 million medical malpractice verdict, saying the jury rightfully found that the healthcare professionals didn't act correctly and that the hospital is liable.

  • January 23, 2024

    Equipment Co. Can't Sue NY Hospital To Recoup Settlement

    A Texas appellate panel on Tuesday rejected an appeal from an equipment rental company seeking to recoup a wrongful death settlement from a New York hospital, saying there's no evidence that the hospital agreed to a forum selection clause that would give the Texas courts jurisdiction.

  • January 23, 2024

    DOJ Seeks Dismissal Of Challenge To Federal Cannabis Ban

    The U.S. Department of Justice on Tuesday urged a Massachusetts federal judge to dismiss a legal challenge to the federal prohibition on marijuana, arguing that courts have consistently upheld the federal government's ban on pot and rejected previous efforts to overturn it.

  • January 23, 2024

    Del. Judge Nixes Bidder Fees In Humanigen Ch. 11

    A Delaware bankruptcy judge Tuesday partially rejected bidding procedures for biopharmaceutical company Humanigen Inc.'s assets, saying a proposed $200,000 in bidding protections for the stalking horse bidder, which is also the DIP lender, was disproportionate to the $2 million purchase price.

  • January 23, 2024

    W.Va. County To Face Off With Opioid Distributors At 4th Circ.

    A Fourth Circuit panel will hear oral arguments Thursday morning in an appeal brought by a West Virginia county that lost the first bench trial in multidistrict litigation over the opioid epidemic, kicking off the first appellate arguments this year over verdicts in the MDL.  

  • January 23, 2024

    Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says

    The liquidation trustee of Insys Therapeutics on Tuesday asked a Delaware bankruptcy judge for an injunction preventing the pharmaceutical company's former CEO Michael L. Babich from pursuing counterclaims in a clawback suit from the trustee in Delaware's Chancery Court.

  • January 23, 2024

    6th Circ. Rejects PREP Act Immunity For Doc In Med Mal Suit

    A doctor and medical provider can't ditch a woman's suit over an abdominal bleed that necessitated emergency surgery on the basis of immunity under the Public Readiness and Emergency Preparedness Act, a Sixth Circuit appellate panel has found, saying the suit doesn't back their claim that they treated the patient due to a COVID-19 vaccine side effect.

  • January 23, 2024

    Fed. Circ. Sends Xencor Antibody Patent Case Back To USPTO

    The Federal Circuit has granted the U.S. Patent and Trademark Office's bid to send Xencor Inc.'s application for an antibody patent back for further proceedings to a new administrative appellate panel.

  • January 23, 2024

    Split 9th Circ. Revives Nurse's Disability Benefits Suit

    A divided Ninth Circuit panel has reinstated a nurse's lawsuit alleging an insurer wrongly denied her long-term disability benefits, saying a prior suit she brought against the company — which resulted in her winning short-term benefits at trial — doesn't get in the way of the current one.

  • January 23, 2024

    Mich. Justices Won't Hear Hospital Stroke Treatment Suit

    The Michigan Supreme Court has declined to grant a hearing in an appeal challenging the dismissal of vicarious liability claims against a hospital over a patient whose stroke was allegedly not treated fast enough.

  • January 23, 2024

    Medical Scrubs Co. Enters Ch. 11 As COVID Biz Boost Slows

    Global medical scrubs distributor Careismatic Brands LLC and 21 affiliates filed for Chapter 11 bankruptcy protection in New Jersey with a prearranged restructuring plan after business normalized last year following an earlier surge in COVID-19-related revenues.

  • January 22, 2024

    Seattle Hospital To Blame For Children's Suffering, Jury Told

    A father testified to a Washington state jury on Monday that a Seattle hospital's mistakes exposing his infant daughter to dangerous mold during open-heart surgery forced her into treatment that made her unrecognizable, kicking off a bellwether class trial.

  • January 22, 2024

    Conn. Burn Charity's Bookkeeper Stole Funds, $2M Suit Says

    A Connecticut-based burn treatment and prevention charity has sued the estate of its longtime bookkeeper for around $2 million after allegedly discovering, upon her sudden death, that she had embezzled more than $655,000.

  • January 22, 2024

    Investors Sue Biopharma Co. After Clinical Trial Data Toss

    Biopharmaceutical company BioVie and three of its executives are facing an investors' proposed class action after "suspected coordinated improprieties" led the company to toss data for over 80% of the subjects in a clinical trial for a proposed treatment for Alzheimer's disease.

  • January 22, 2024

    Zantac Class Attys Urge Del. Judge To Keep Experts In Case

    Attorneys for tens of thousands of individuals claiming the once widely sold heartburn drug Zantac caused multiple cancers urged a Delaware judge on Monday to reject calls from the drug company defendants to exclude the plaintiffs' expert reports and testimony, saying jurors should weigh the findings.

  • January 22, 2024

    3 Takeaways From Health Officials' Marijuana Proposal

    Federal health regulators have acknowledged for the first time that marijuana has a currently accepted medical use, can be safe to use under medical supervision and has fewer associated dangers than other highly restricted drugs and even alcohol.

  • January 22, 2024

    Medical Practice Execs Call Health Co. Suit 'Vendetta'

    Three former executives of a bankrupt Massachusetts medical practice told a judge on Monday that financially troubled Steward Medical Group's efforts to put them on the hook for a $16 million jury award are nothing more than a "personal vendetta" based on "rank speculation" and baseless accusations.

  • January 22, 2024

    Settlement Nears For Aetna, Optum Administrative Fee Class

    A settlement is looming in a patient's certified class claims accusing Aetna Inc. and OptumHealth Care Solutions LLC of conspiring to dupe patients into paying administrative fees by dressing them up as medical expenses, according to a filing in North Carolina federal court.

  • January 22, 2024

    Moderna Wants UPenn Biochemist's Emails In Vax IP Dispute

    Moderna has asked a federal judge to order a University of Pennsylvania biochemist to turn over a set of emails and documents that could be relevant to an underlying COVID vaccine-related patent dispute with rival biotech giants Pfizer and BioNTech.

  • January 22, 2024

    Medical Software Co. Eye Care Leaders OK'd For Joint Ch. 11

    Eye doctor practice management software maker Eye Care Leaders and its 34 affiliates were approved for a joint Chapter 11 bankruptcy Monday, with attorneys for the company telling a Dallas bankruptcy judge that it plans to restructure, sell its assets or use a combination of both approaches to pay off debts.

  • January 22, 2024

    Motley Rice Fights DQ Bid In Opioid MDL

    Law firms representing governments suing over the opioid epidemic on Monday told an Ohio federal judge that "corporate wrongdoers" don't get to pick who sues them, in response to a pharmacy benefit manager's bid to disqualify Motley Rice LLC over its representation of other governments in prescription drug disputes.

  • January 22, 2024

    HIV Drug Wholesalers' Attys Get $75M In Gilead Antitrust Case

    A California federal judge has given final approval to Gilead Sciences' $247 million settlement with direct purchasers of HIV medications, including an award of $75 million for attorney fees, ending claims the pharmaceutical giant worked with Teva Pharmaceuticals to delay generic versions.

  • January 22, 2024

    Catching Up With Delaware's Chancery Court

    Last week in Delaware's Court of Chancery, a dating app found a way to ease some relationship tension, burned up stockholders sued an energy giant, and a vice chancellor got some supreme validation for his dismissal of a shareholder suit against Snap Inc. and Fox Corp.

  • January 22, 2024

    Mich. Justice Warns Of 'Endless' Appeals After Panel Flip-Flop

    Two Michigan Supreme Court justices decried their colleagues' decision Friday not to take up a reinstated $20 million verdict against a hospital, writing that the court was now leaving in place an "unworkable rule" that would allow intermediate appellate panels to overrule one another. 

  • January 22, 2024

    Health Groups Must Face Suit Over Spine Drain Injury

    A Michigan appeals panel has revived a suit against a hospital and medical group over a piece of drainage tube left in a patient, saying there's evidence suggesting the nurse practitioner in charge of his care should have realized the drain was damaged when it was removed.

Expert Analysis

  • Establishing Bad Faith In Removal Claims

    Author Photo

    Recent precedent from federal courts in South Carolina and other jurisdictions shows that bad faith in removal claims can be established when defendants present clear evidence of plaintiffs intentionally delaying or withholding pertinent information — but defendants must be able to back up their assertions, says Denver Smith at Butler Snow.

  • Lessons From 1st COVID Biz Interruption Policyholder Verdict

    Author Photo

    Robyn Anderson at Lathrop examines what made Baylor College of Medicine's recent COVID-19 business interruption case a success in Texas state court, and considers whether this first win on behalf of an insured is an outlier or a sign of more to come.

  • No-Poach Plea Hiccups Point To DOJ's Unsound Theory

    Author Photo

    After a series of setbacks, the U.S. Department of Justice could soon obtain its first no-poach conviction, but complications in a recent change-of-plea hearing demonstrate that the government’s problems may continue as long as it incorrectly insists that labor cases are the same as any other antitrust conspiracy, say Mark Butscha and Matthew Ridings at Thompson Hine.

  • State COVID Insurance Rulings Highlight Errors In Dismissals

    Author Photo

    Recent California and Vermont decisions in favor of policyholders, along with a $48 million jury verdict in Texas, underscore the error that courts are making by dismissing COVID-19 business interruption lawsuits at the pleading stage without consideration of the facts and evidence in each case, say Joseph Niczky and Michael Levine at Hunton.

  • Recent Cases Guide On Use Of Experts In Employment Trials

    Author Photo

    Experts can help judges and juries understand a range of issues in employment litigation, from statistical data to damages, and recent cases involving admissibility challenges provide lessons for the careful selection of experts to meet Daubert standards, say Kathleen Anderson and John Maley at Barnes & Thornburg.

  • 2nd Circ. Shkreli Atty Ruling Guides On 401(k) Garnishment

    Author Photo

    The Second Circuit’s recent holding that the government could garnish the 401(k) accounts of Martin Shkreli’s co-conspirator attorney shows that those facing criminal charges should prepare for the possibility that their retirement accounts may be subject to garnishment in order to satisfy restitution orders, say Brea Croteau and Edward Novak at Polsinelli.

  • Physician Noncompetes May Get Federal Antitrust Treatment

    Author Photo

    While interpretation and enforcement of health care noncompete agreements have traditionally been viewed as state law matters, the agreements are increasingly facing scrutiny of their anticompetitive effects at a national level, say John Zen Jackson and Jessica Carroll at Greenbaum Rowe.

  • 3rd Time May Be The Charm For Florida Cannabis Legalization

    Author Photo

    After two unsuccessful attempts at legalizing adult-use cannabis in Florida, strong electoral support combined with significant financial backing for a recently approved constitutional ballot initiative may finally result in success, say Ashlee Tising and Jonathan Robbins at Akerman.

  • FOIA Ruling Yields New Argument For Challenging Exemption

    Author Photo

    The Second Circuit recently became the first appellate court to address the 2016 FOIA Improvement Act's impact on a key exemption of the Freedom of Information Act, providing FOIA requestors with a new argument to challenge exemption claims that are based on confidentiality and competitive harm, and requiring courts to assess the credibility of such claims, say attorneys at Crowell & Moring.

  • 7th Circ. 'Reasonable Costs' Ruling Is A Win For Policyholders

    Author Photo

    The Seventh Circuit's decision in USA Gymnastics v. Liberty Insurance last month establishes useful precedent for policyholders, affirming and expanding on its rule that defense costs are presumed to be reasonable and necessary when insurers breach their duty to defend, say attorneys at Reed Smith.

  • Courts Are Not Shifting On COVID Biz Interruption Stance

    Author Photo

    Although a recent Law360 guest article suggested that the pendulum is about to swing in favor of policyholders seeking business interruption coverage for pandemic-related losses, the larger body of appellate case law — applying the laws of 25 states — continues to find no coverage, say attorneys at Dentons.

  • FTC Settlement Puts Contact Lens Compliance In Sharp Focus

    Author Photo

    The Federal Trade Commission's recent $3.5 million settlement with Vision Path over improper online sales of prescription contact lenses, and related online reviews, demonstrates that companies must eye their legal responsibilities under the Contact Lens Rule and the FTC Act carefully to mitigate legal risks and liability, says David Oberly at Squire Patton.

  • Why Creditors Should Beware Of SBRA Due Diligence Defense

    Author Photo

    The Delaware bankruptcy court’s recent holding in the Center City Healthcare Chapter 11 case highlights courts' reluctance to interpret the Small Business Reorganization Act as requiring bankruptcy plaintiffs to undertake any additional due diligence, which means trade creditors should beware of seeking to dismiss a preference claim on those grounds, say Eric Chafetz and Lindsay Sklar at Lowenstein Sandler.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.